Collectins and fungal pathogens: Roles of surfactant proteins and mannose binding lectin in host resistance

Medical Mycology

Volumn 48, Issue 1, 2010, Pages 16-28

  Brummer, Elmer ^a,b   Stevens, David A ^a,b  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Collectins; Mannose binding lectin; Surfactant proteins

Indexed keywords

COLLECTIN; LUNG SURFACTANT; MANNOSE BINDING LECTIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; PROTEIN BINDING; SURFACTANT;

ASPERGILLUS FUMIGATUS; BLASTOMYCES DERMATITIDIS; CANDIDA ALBICANS; COCCIDIOIDES; COMPLEMENT FIXATION; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; HISTOPLASMA CAPSULATUM; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PHAGOCYTOSIS; PNEUMOCYSTIS; PROTEIN STRUCTURE; REVIEW; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; FUNGUS; IMMUNOLOGY; METABOLISM;

AJELLOMYCES CAPSULATUS; AJELLOMYCES DERMATITIDIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; COCCIDIOIDES; FILOBASIDIELLA NEOFORMANS; FUNGI; PARACOCCIDIOIDES BRASILIENSIS; PNEUMOCYSTIS;

ANIMALS; COLLECTINS; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MANNOSE-BINDING LECTIN; MODELS, BIOLOGICAL; MYCOSES; PROTEIN BINDING; SURFACE-ACTIVE AGENTS;

EID: 74949141938     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903117473     Document Type: Review

References (129)

1. Gupta B, Surolia A. Collectins: sentinels of innate immunity. Bio Essays 2007; 29: 452-464.
2. Crouch EC. Collectins and pulmonary defense. Am J Respir Cell Mol Biol 1998; 19: 177-201.
3. Poynter SE, LeVine AM. Surfactant biology and clinical application. Crit Care Clin 2003; 19: 459-472.
4. Lawson PR, Reid KBM. The roles of surfactant proteins A and D in innate immunity. Immun Rev 2000; 173: 66-78.
5. Hickling TP, Clark H, Malhotra R, Sim RB. Collectins and their role in lung immunity. J Leuk Biol 2004; 75: 27-33.
6. Clark HW, Reid KBM, Sim RB. Collectins and innate immunity in the lung. Microbes Infect 2000; 2: 273-278.
7. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 2007; 9: 1871-1879.
8. LeVine AM, Bruno MD, Huelsman KM, et al. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997; 158: 4336-4340.
9. Sato H, Sano H, Iwaki D, et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A. J Immunol 2003; 171: 417-425.
10. Ezekowitz RA. Role of the mannose-binding lectin in innate immunity. J Infect Dis 2003; 187 ( Suppl. 2 ): S335-S339.
11. Degn SE, Thiel S, Jensenius JC. New perspectives on mannan-binding lectin-mediated complement activation. Immunobiology. 2007; 212: 301-311.
12. Selander B, Martensson U, Weintraub A, et al. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 2006; 116: 1425-1434.
13. Hansen S, Thiel S, Willis A, Holmskow U, Jensenius JC. Purification and characterization of two mannan-binding lectins from mouse serum. J Immunol 2000; 164: 2610-2618.
14. Turner MW. The role of mannose-binding lectins in health and disease. J Med 2004; 62: 4-9.
15. Jack DL, Turner MW. Antimicrobial activities of mannose-binding lectins. Biochem Soc Trans 2003; 31: 753-757.
16. Worthley DL, Bardy PG, Mulligham CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005; 35: 548-555.
17. Tacx AN, Hart MHL, Groeneveld ABJ. Role of mannose-binding lectin in host defense. In: Vincent JL (ed.). Intensive Care Medicine: Annual Update 2005. New York: Springer, 2005.
18. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
19. Butler P, Schmidt B, Schikor D, et al. Surfactant protein A and D differently regulate immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol 2003; 28: 249-256.
20. Gold JA, Hoshino Y, Tanaka N, et al. Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun 2004; 72: 645-650.
21. Schaeffer LM, McCormack FX, Wu H, Weiss AA. Interaction of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate structural basis of antimicrobial activities. Infect Immun 2004; 72: 7124-7130.
22. Atochina EN, Beck JM, Preston AM, et al. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein Adeficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun. 2004; 72: 6002-6011.
23. Madan T, Eggleton P, Kishor U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65: 3171-3179.
24. Bianca A, Van Rozendaal WM, Van Spriel AB, Vande Winkel JDJ, Haagsman HP.. Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 2000; 182: 917-922.
25. Hartshorn KL, Reid KB, White MR, et al. Neutrophil deactivation of infl uenza A viruses: mechanism of protection after viral opsonization with collectins and hemagglutinating antibodies. Blood 1996; 87: 3460-3461.
26. Van Iwaarden JF, Van Sripp JA, Elskamp MJ, et al. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type I by rat alveolar macrophages. Am J Physiol 1991; 261: L204-L209.
27. Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693.
28. Nadesalingam J, Dodds AW, Reid KBM, Palaniyar N. Mannosebinding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol 2005; 175: 1785-1794.
29. Jack DL, Read RC, Tenner AJ, et al. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001; 184: 1152-1162.
30. Gadjeva M, Takehashi K, Thiel S. Mannan-binding lectin- a soluble recognition molecule. Mol Immunol 2004; 41: 113-121.
31. Casanova J-L, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both ? J Exp Med 2004; 199: 1295-1299.
32. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present, and future. Tissue Antigens 2006; 68: 193-209.
33. Takahashi K, Ezekowitz RAB. The role of mannose-binding lectin in innate immunity. Clin Infect Dis 2005; 41 ( Suppl.7 ): S440-S444.
34. Sprong T, van Deuren M. Mannose binding lectin: ancient molecule, interesting future. Clin Infect Dis 2008; 47: 517-518.
35. Granell M, Urbano-Ispizua A, Suarez B, et al. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogenic stem cell transplantation. Exp Hematol 2006; 34: 1435-1441.
36. Mulligan CG, Heatley S, Doherty K, et al. Mannan-binding lectin gene polymorphisms are associated with major infection following allogeneic stem cell transplantation. Blood 2002; 99: 3524-3529.
37. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population- based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199: 1391-1399. (Pubitemid 38685730)
38. Lekkala M, LeVine AM, Linke MJ, et al. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis : inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun 2006; 74: 4549-4556.
39. Rosseau S, Hammerl P, Mares U, et al. Surfactant protein A downregulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. J Immunol 1999; 163: 4495-4502.
40. Wakenkamp AM, Verheul MAF, Sharringa J, Hoepelman IM. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur J Clin Invest 1999; 29: 83-92.
41. Koneti A, Linke MJ, Brummer E, Stevens DA. Evasion of innate immune responses: evidence for mannose binding protein inhibition of TNF-α production by macrophages in response to Blastomyces dermatitidis. Infect Immun 2008; 76: 994-1002.
42. Ip WK, Lau YL. Role of mannose-binding lectin in the innate defense against Candida albicans : enhancement of complement activation, but lack of opsonic function in phagocytosis by human dendritic cells. J Infect Dis 2004; 190: 632-640.
43. Chaka W, Verheul AF, Vaihnov VV, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997; 159: 2979-2985.
44. Vande Wetering JK, Coenjaerts FEJ, Vaandrager AB, Van Golde LMG, Batenburg J.. Aggregation of Cryptococcus neoformans by surfactant protein D inhibited by its capsular component glucuronoxylomannan (GXM). Infect Immun 2004; 72: 145-153.
45. Scheleng S, Malhartra R, Sim RB, Holmskow U, Bancroft GJ. Binding of pathogenic yeast Cryptococcus neoformans : human surfactant protein D act as an agglutinin for yeast cells. Infect Immun 1995; 63: 3360-3366.
46. Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Carbohydrate recognition domain of surfactant protein D mediates interaction with Pneumocystis carinii glycoprotein A. Am J Respir Cell Mol Biol 2001; 24: 475-484.
47. Zimmerman PE, Voelker DR, McCormack FX, Paularud JR, Martin WJ. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992; 89: 143-149.
48. Kitz DJ, Stahl PD, Little JR. The effect of a mannose-binding protein on macrophage interactions with Candida albicans. Cell Mol Biol 1992; 38: 407-412.
49. van Asbeck E, Hoepelman AIM, Scharringa J, Herpers BL, Verhoef J. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol 2008; 8: 229-238.
50. Selitrennikoff CP, Ostroff GR. Emerging therapeutic cell wall targets in fungal infections. Emerging Ther Targets 1999; 3: 53-72.
51. Sano H, Chiba H, Iwaki D, et al. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 275: 22442-22451.
52. Kamberi M, Brummer E, Stevens DA. Regulation of bronchoalveolar macrophages proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony stimulating factor after stimulation by Aspergillus conidida or lipopolysaccarhide. Cytokine 2002; 19: 14-20.
53. Brummer E, Kamberi M, Stevens DA. Regulation by granulocytemacrophage colony stimulating factor and/or steroid given in vivo on proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidida. J Infect Dis 2003; 187: 705-709.
54. Gardi SJ, Xiao YQ, Dickinson M, et al. By binding SIRPa or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance infl ammation. Cell. 2000; 115: 13-23.
55. Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate direct actin-based responses in alveolar macrophages in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 1999; 276: 169-174.
56. Veillette A, Thibaudeau E, Latour S. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J Biol Chem 1998; 273: 22719-22728.
57. Madan T, Kano S, Singh M, et al. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005; 43 ( Suppl. 1 ): S155-S163.
58. Madan T, Reid KBM, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens or allergens of Aspergilllus fumigatus. J Immunol 2005; 174: 6943-16054
59. Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007; 148: 382-389.
60. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653-656.
61. Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007; 45: 183-186.
62. Hogaboam CM, Takahashi K, Ezekowitz RA, Kunkel SL, Schuh JM. Mannose binding lectin deficiency alters the development of fungal asthma: effects on airway response, infl ammation, and cytokine profi le. J Leuk Biol 2004; 75: 805-814.
63. Clemons KV, Tong AJ, Martinez M, Stevens DA, Susceptibility of mannose binding lectin (MBL) gene knockout mice to experimental systemic aspergillosis. 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Ann. Meeting of the Infectious Diseases Society of America , Washington , DC , 2008, Abstract no. M-1578.
64. Chung D, Ding L, Amigues I, et al. Association of mannose binding lectin (MBL-2) deficiency with pulmonary infection after allogeneic hematopoietic stem cell transplantation (HSCT). Blood 2008; 112 : 2209 (abstract).
65. Anaissie EJ, Zhao W-Z, Wen Y-J, et al. Deficiency of mannosebinding lectin is a risk factor for invasive aspergillosis in patients with multiple myeloma: an analysis of 482 patients. Blood 2008; 112 : 667 (abstract).
66. Lambourne J, Agranoff D, Buchbinder A, et al. Mannose-binding lectin deficiency- a risk factor for invasive aspergillosis in immunocompromised patients. Blood (ASM Annual Meeting Abstracts) 2008; 112 : 1465 (abstract).
67. Wang Y, Liu T, Gong H, Zhou Q, Sun S, Xie L. Gene profi ling in murine corneas challenged with Aspergillus fumigatus. Mol Vis 2007; 13: 1226-1233.
68. Denton JF, DiSalvo AF. Isolation of Blastomyces dermatitidis from natural sites at Augusta, Georgia. Am J Trop Med Hyg 1964; 13: 716-722.
69. Sugar AM, Picard M. Experimental blastomycosis pneumonia in mice by infection with conidia. J Med Vet Mycol 1988; 26: 321-325.
70. Brummer E, KethinenIn, Stevens DA. Immunological basis for susceptibility and resistance to plumonary blastomycosis in mouse strains. Cytokine 2005; 32: 12-19.
71. KethinenIn, Brummer E, Stevens DA. Susceptibility to pulmonary blastomycosis in young compared to adult mice: deficiencies in young mice. Med Mycol 2006; 44: 51-60.
72. Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002; 196: 407-412.
73. Kimberg M, Brown GD.. Dectin-1 and its role in antifungal immunity. Med Mycol 2008; 46: 631-636.
74. Levine AM, Whitsett JA, Gwozdz JA, et al. Distinct effects of surfactant protein A and D deficiencies during bacterial infection on the lung. J Immunol 2000; 165: 3934-3939.
75. Brummer E, Capilla J, Bythadka L, Stevens DA. Production of IL-6, contrast to other cytokines and chemokines, in macrophage innate immune responses: effect of serum and fungal ( Blastomyces ) challenge. Cytokine 2007; 39: 163-170.
76. Xing Z, Gauldie J, Cox G, et al. IL-6 is an anti-inflammatory cytokine required for controlling local and systemic responses. J Clin Invest 1998; 101: 311-320.
77. Stevens DA. Fungal infections in AIDS patients. Brit J Clin Prac. 1990; 44: 12-21.
78. Rosseau S, Hammerl P, Maus U, et al. Surfactant protein A downregulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. J Immunol 1999; 163: 4494-4502.
79. Rosseau S, Guenther A, Seeger W, Lohmeyer J. Phagocytosis of viable Candida albicans by alveolar macrophages: lack of opsonin function of surfactant protein A. J Infect Dis 1997; 175: 421-428.
80. Van Rosendaal BAWM, Van Spriel AB, Vande Winkel JGI, Haagsman HP. Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 2000; 185: 917-922.
81. Ghezzi MC, Raponi G, Angelettii S, Mancini C. Serum medicated enhancement of TNF-alpha release by monocytes stimulated with yeast form of Candida albicans. J Infect Dis 1998; 178: 1743-1749.
82. Lillegard JB, Sim RB, Thorkildson P, Gates MA, Kozel TR. Recognition of Candida albicans by mannose-binding lectin in vitro and in vivo. Serum mediated enhancement of TNF-alpha releaseby monocytes simulated with yeast form of candida albicans J Infect Dis 2006; 193: 1589-1597.
83. van Till JW, Modderman PW, de Boer M, et al. Mannosebinding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis. Clin Vaccine Immunol 2008; 15: 65-70.
84. Held K, Thiel S, Loos M, Petry F. Increased susceptibility of complement factor B/C2 double knockout mice and mannose-binding lectin knockout mice to systemic infection with Candida albicans. Mol Immunol 2008; 45: 3934-3941.
85. Sealy PI, Garner B, Swiatlo E, Chapman SW, Cleary JD. The interaction of mannose-binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection. Med Mycol 2008; 46: 531-539.
86. Pellis V, DeSeta F, Crovella S, et al. Mannose-binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin Exp Immunol 2005; 139: 120-126.
87. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. Relation between recurrent vulvovaginal concentrations of mannose-binding lectin, and a mannose- binding gene polymorphism in Latvian women. Clin Infect Dis 2003; 37: 733-737.
88. Liu F, Liao Q, Liu Z. Mannose-binding lectin and vulvovaginal candidiasis. J Gyn Obstet 2005; 92: 43-47.
89. Giraldo PC, Babula O, Goncalves AKS, et al. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet Gynecol 2007; 109: 1123-1128. (Pubitemid 46685956)
90. Donders GG, Babula O, Bellen G, Linhares IM, Witkin SS. Mannose- binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. Br J Obstetr Gynae 2008; 115: 1225-1231.
91. Milanese M, Segat L, De Seta F, et al. MBL2 genetic screening in patients with recurrent vaginal infections. Am J Reprod Immunol 2008; 59: 146-151.
92. Clemons KV, Martinez M, Tong AJ, Axelsen M, Stevens DA, Efficacy of topical recombinant human mannose binding lectin against Candida albicans vaginitis in mannose binding lectin deficient mice. Infect Dis Soc Amer (IDSA), 45th Ann Meet, 2007 , San Diego , CA , Abstr. 183.
93. Clemons KV, Martinez M, Axelsen M, Stevens DA. Efficacy of recombinant human mannose binding lectin alone or in combination against experimental murine vaginitis. Intersci Conf Antimicrob Agents Chenmother (ICAAC), 46th Ann Meet, 2006, San Francisco, CA. Abstr. B-1327.
94. Mitchell TG, Perfect JR. Cryptococcosis era of AIDS-100 years after discovery of Cryptococcus neoformans. Clin Micro Rev 1995; 8: 515-548.
95. Brummer E, Stevens DA. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine. Cell Immun 1994; 57: 1-10.
96. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor-alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975-1981.
97. Levitz SM, Tabuni A, Treseler C. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun 1993; 61: 4891-4893.
98. Eisen DP, Dean MM, OSullivan MVN, Heatley S, Michinton RM. Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients. Med Mycol 2008; 46 : 371-375.
99. Goodwin R, Des Prez R. Histoplasmosis. Am Rev Respir Dis 1978; 117: 929-956.
100. Long KH, Gomez FJ, Morris R, Newman SL. Identification of heat shock protein 60 as the ligand on Histoplasma casulatum that mediates binding to CD 18 receptors on human macrophages. J Immunol 2003; 170: 487-494.
101. McCormack FX, Gibbons R, Ward SR, et al. Macrophageindependent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278: 36250-36256.
102. Rappleye CA, Eisenberg LF, Goldman WE. Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the -glucan receptor. Proc Nat Acad Sci 2007; 104: 1366-1370.
103. Kimpel KR, Goldman WE. Cell walls from avirulent variants of Histoplasma capsulatum lack α-(1,3)-glucan. Infect Immun 1988; 56: 2997-3000.
104. Gauthier G, Klein BS.. Insights into fungal morphogenesis and immune evasion. Microbe 2008; 3: 416 - 423.
105. Gigliotti F. Pneumocystis carinii: has the name really been changed?. Clin Infect Dis 2005; 41: 1752 - 1755.
106. Cushion MT, Stringer JR. Has the name really been changed? It has for most researchers. Clin Infect Dis 2005; 41: 1756-1758.
107. Bartlett MS, Vermund SH, Jacobs R, et al. Detection of Pneumocystis carinii DNA in air samples: likely environment risk to susceptible persons. J Clin Microbiol 1997; 35: 2511-2513.
108. Thomas CF, Limper AH.. Pneumocystis pneumonia. N Engl J Med 2004; 350: 2487-2498.
109. Linke M, Ashbaugh A, Koch J, Tanaka Walzer P. Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of coricosteroid- induced immunosuppression. J Med Microbiol 2006; 55: 143-147.
110. Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A. Respir Cell Mol Biol 2001; 24: 475-484.
111. O'Riordan DM, Standing JE, Kwon KY, et al. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to macrophages. J Clin Invest 1995; 95: 2699-2710.
112. Vassallo R, Standing JE, Limper AH. Isolated P neumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000; 164: 3755-3763.
113. Steele C, Marrero L, Swain S, et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by Dectin-1 beta-glucan receptor. J Exp Med 2003; 198: 1677-1688.
114. Williams MD, Wright JR, March KL, Martin WJ. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 1996; 14: 232-238.
115. Zhu S, Kachel DL, Martin WJ, Matalon S. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 1998; 275: L1031-L1039.
116. Stevens DA. Coccidioidomycosis. N Engl J Med. 1995; 332: 28-40
117. Awasthi S, Magee DM, Coalson J. C occidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)A and SP-D. Respir Res 2004; 5: 28-40.
118. Viriyakosol S, Fierer J, Brown GD, Kirkland TN.. Innate immunity to pathogenic fungus Coccidioides posadasii is dependent on Toll-Like receptor 2 and Dectin-1. Infect Immun 2005; 73: 1553-1560.
119. Ampel N, Dionne SO, Giblin A, Podany AB, Galgiani J. Mannose-binding lectin serum levels are low in persons with clinically active coccidioidomycosis. Mycopathologia 2009; 167: 173-180.
120. Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Micro Rev 1993; 6: 89-117. (Pubitemid 23984222)
121. Corredor GG, Castano JH, Peralta LA, et al. Isolation of Paracoccidioides brasiliensis from the nine-banded armadillo, Dasypus noveminctus , in an endemic area for paracoccidioidomycosis in Colombia. Rev Iberoam Micol 1999; 16: 216-220.
122. Bagagli E, Sano A, Coelho KI, et al. Isolation of Paracoccidioides - brasiliensis from armadillos ( Dasypsu noveminctus ) captured in an endemic area of paracoccidioidomycosis. Am J Trop Med Hyg 1998; 28: 505-512.
123. San-Blas G, San-Blas F. Variability of cell wall composition in Paracoccidioides brasiliensis : a study of two strains. Sabouraudia. 1982; 20: 31-40.
124. San-Blas G, San-Blas F. P aracoccidioides brasiliensis : cell wall structure and virulence; a review. Mycopathologia. 1977; 62: 77-86.
125. Clemons KV, McCusker JH, Davis RW, Stevens DA. S accharomyces cerevisiae and the host-fungus interplay. In: Vanden Bossche H, Odds FC, Stevens DA (eds). Host-Fungus Interplay. Bethesda, MD: National Foundation for Infectious Diseases, 1997: 193-198.
126. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonization. Lancet 1989; 2: 1236-1239.
127. Peterson KA, Matthiesen F, Agger T, et al. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2006; 26: 465-475.
128. Valdimarsson H, Vikingsdottir T, Bang P, et al. Human plasmaderived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59: 97-102.
129. Lu J, Teh C, Kishore U, Reid KBM. Collectins and fi colins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 2002; 1572: 387-400.